SYSTEMATIC REVIEW article
Front. Med.
Sec. Gastroenterology
Endoscopic Submucosal Dissection versus Endoscopic Mucosal Resection for early gastric cancer: A meta-analysis
Provisionally accepted
Xiaoli Zheng
Long Xu*- Shenzhen University General Hospital, Shenzhen, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: This study aimed to evaluate the efficacy and safety of endoscopic mucosal resection (EMR) versus endoscopic submucosal dissection (ESD) in the treatment of early gastric cancer (EGC) through a meta-analysis, and to provide evidence-based guidance for clinical decision-making. Methods: Relevant studies were systematically retrieved from PubMed, EMBASE, Web of Science, the Cochrane Library, and major Chinese databases. Randomized controlled trials (RCTs) comparing EMR and ESD for EGC were included. Meta-analysis was performed using Review Manager 5.3 software. The primary outcomes included en bloc resection rate, curative resection rate, local tumor recurrence, procedure time, and complications. Subgroup analyses were performed according to procedure time, follow-up duration, and lesion type to explore potential sources of heterogeneity. Results: A total of nine studies comprising 3,574 patients were included. The results showed that ESD was associated with significantly higher en bloc resection and curative resection rates compared to EMR (OR = 4.00, P < 0.00001; OR = 1.95, P < 0.00001, respectively), and a significantly lower postoperative recurrence rate (OR = 1.97, P < 0.00001). However, ESD required longer procedure time and involved higher technical complexity, demanding advanced endoscopic skills. Subgroup analyses revealed that the advantages of ESD were more pronounced in patients with differentiated-type lesions (OR = 3.85, P < 0.001), procedures longer than 120 minutes (OR = 3.45, P < 0.001), and in settings with follow-up durations exceeding 3 years (OR = 4.20, P < 0.001).. Conclusion: ESD provides superior therapeutic efficacy over EMR in early gastric cancer, particularly in differentiated lesions and long-term follow-up settings, though it demands greater technical expertise and longer operative time. These findings support ESD as the preferred approach for appropriately selected EGC patients.
Keywords: earlygastriccancer, endoscopicmucosalresection, Endoscopicsubmucosal dissection, Meta-analysis, therapeutic efficacy, subgroup analysis
Received: 10 Sep 2025; Accepted: 10 Nov 2025.
Copyright: © 2025 Zheng and Xu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Long Xu, xiaoliz2025@163.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.